Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,066 | 10,250 | 16,904 | 19,110 | 21,006 |
| Other current assets | 715 | 691 | 689 | 649 | 764 |
| TOTAL | $9,579 | $12,074 | $19,066 | $21,126 | $22,680 |
| Non-Current Assets | |||||
| PPE Net | 697 | 789 | 895 | 1,011 | 1,134 |
| Other Non-Current Assets | 4,645 | 4,766 | 4,881 | 4,992 | 5,098 |
| TOTAL | $5,342 | $5,555 | $5,776 | $6,003 | $6,232 |
| Total Assets | $14,921 | $17,629 | $24,842 | $27,129 | $28,912 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,736 | 3,720 | 3,984 | 4,000 | 4,873 |
| Accrued Expenses | 892 | 1,610 | 2,098 | 1,525 | 1,292 |
| Other current liabilities | 791 | 968 | 1,142 | 1,311 | 746 |
| TOTAL | $5,419 | $6,298 | $7,224 | $6,836 | $6,911 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,039 | 5,228 | 5,397 | 5,575 | 5,748 |
| TOTAL | $5,039 | $5,228 | $5,397 | $5,575 | $5,748 |
| Total Liabilities | $10,458 | $11,526 | $12,621 | $12,411 | $12,659 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13 | 6 | 1 | 1 | 0 |
| Common Shares | 69 | 66 | 61 | 56 | 49 |
| Retained earnings | -236,164 | -230,281 | -223,447 | -217,545 | -211,211 |
| TOTAL | $4,463 | $6,103 | $12,221 | $14,718 | $16,253 |
| Total Liabilities And Equity | $14,921 | $17,629 | $24,842 | $27,129 | $28,912 |